Feature | Coronavirus (COVID-19) | April 01, 2020| Dave Fornell, Editor

Heart Rhythm Society Cancels 2020 Meeting Due to COVID-19

While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions. #HRS #COVID19 #coronavirus #SARScov2

While the HRS annual meeting is cancelled, the society has created a resource page to help its members in the fight against COVID-19 at https://www.hrsonline.org/COVID19-Challenges-Solutions

April 1, 2020 — Due to the continued global escalation of the novel coronavirus (COVID-19, SARS-CoV-2), the Heart Rhythm Society (HRS) has cancelled its large annual electrophysiology meeting that was slated for May 6-9, 2020, in San Diego.

"Our careful evaluation of evolving government advisories, available alternatives, and most importantly the health and well-being of our attendees, the Heart Rhythm Society Board of Trustees regrets to announce that the 2020 Heart Rhythm Scientific Sessions is cancelled," HRS said in a statement sent out this morning.
 
This is the first time in the history of the society that it has ever cancelled an annual meeting. "The decision to cancel was not an easy one, but it was the right choice during these unprecedented events," HRS stated.

Instead of meeting in person, HRS will offer several new digital programs over the next few months on our online learning platform, Heart Rhythm 365. These programs will be available starting May 6, including the #HRS2020 Abstract E-Poster Catalog, Late-Breaking Clinical Trial sessions, and the Young Investigator Awards session.

The Society for Cardiovascular Angiography and Interventions (SCAI) decided to cancel its annual meeting last week. It was also schedule for next month, May 13-16. As virus numbers continue to rise rapidly in both Europe and the U.S., it is widely expected other cardiology and other medical conferences scheduled for May and possibly beyond will follow suit. 

The European Heart Rhythm Association (EHRA), HIMSS, the American College of Cardiology (ACC), Society of Interventional Radiology (SIR), European Society of Radiology (ECR), and numerous other conferences have been cancelling like dominoes since early March as containment efforts tightened and as hospitals began putting travel restrictions on staff in case they were needed for emergency plans if the number of COVID-19 cases rapidly expanded. 

ACC decided the show must go on and hastily created a shorten virtual ACC meeting platform, in which more 38,006 clinicains from 157 countries participated. ACC made the sessions free, and they are accessile on demand for the next 90 days at https://virtual.acc.org/.

ACC and several other medical societies have created COVID-19 resource pages 

In its cancellation letter, the HRS thanked the Scientific Sessions Program Committee, faculty, abstract presenters, exhibitors, sponsors, partners, media, and countless others for their commitment to this year's Heart Rhythm Scientific Sessions.
 

Related COVID-19 News and Meeting Cancellations:

COVID-19 Cancels SCAI Interventional Cardiology Meeting Set for May 2020 

VIDEO: Cancelling Non-essential Cardiac Procedures During the COVID-19 Outbreak — Interview with SCAI President Ehtisham Mahmud, M.D.

ACC COVID-19 recommendations for the cardiovascular care team

VIDEO: What Cardiologists Need to Know about COVID-19 — Interview with Thomas Maddox, M.D.

The Cardiac Implications of Novel Coronavirus

ESC Council on Hypertension Says ACE-I and ARBs Do Not Increase COVID-19 Mortality

Healthcare Societies Issue Urgent Call for Federal Action to Address COVID-19 Medical Equipment Shortages

Healthcare Societies Issue Urgent Call for Federal Action to Address COVID-19 Medical Equipment Shortages

ACC Cancels 2020 Conference Amid Coronavirus Concerns

SIR 2020 Cancelled Due to COVID-19 Outbreak in Seattle

European Heart Rhythm Association Cancelled Due to Coronavirus

VIDEO: Telemedicine in Cardiology and Medical Imaging During COVID-19 — Interview with Regina Druz, M.D.,

COVID-19 Hydroxychloroquine Treatment Brings Prolonged QT Arrhythmia Issues

Related Content

Left, a 3-D rendering of a heart from a cardiac CT exam. Right, a lung-CT exam showing the heart and ground glass lesions in the lungs of a COVID-19 patient. CT has become a front-line imaging modality in the COVID era because it offers both cardiac and lung information to help determine a patients disposition with chest pain, COVID-19 and COVID-caused myocarditis and pulmonary embolism.

Left, a 3-D rendering of a heart from a cardiac CT exam. Right, a lung-CT exam showing the heart and ground glass lesions in the lungs of a COVID-19 patient. CT has become a front-line imaging modality in the COVID era because it offers both cardiac and lung information to help determine a patients disposition with chest pain, COVID-19 and COVID-caused myocarditis and pulmonary embolism.

Feature | Coronavirus (COVID-19) | July 28, 2020 | Dave Fornell, Editor
July 28, 2020 — The use of cardiova...
Figure B — Top panel, neutrophils noted in collections within small vessels (blue arrow), plump endothelial cells (yellow arrowhead) and a single perivascular dying myocyte (blue arrowhead). Bottom panel, single myocyte undergoing degeneration (blue arrowhead) and plump endothelial cell (yellow arrowhead). Figure C — Electron microscopy, showing particles of SARS-CoV-2 virus present within a cardiac endothelial cell (blue arrowheads), but not present in neighboring cardiac myocyte. #COVID19

Figure B — Top panel, neutrophils noted in collections within small vessels (blue arrow), plump endothelial cells (yellow arrowhead) and a single perivascular dying myocyte (blue arrowhead). Bottom panel, single myocyte undergoing degeneration (blue arrowhead) and plump endothelial cell (yellow arrowhead). Figure C — Electron microscopy, showing particles of SARS-CoV-2 virus present within a cardiac endothelial cell (blue arrowheads), but not present in neighboring cardiac myocyte (left side of image). Images from Circulation.

Feature | Coronavirus (COVID-19) | July 23, 2020
July 23, 2020 - A series of autopsies conducted by Louisiana State University (LSU) Health New Orleans pathologists s
The impact of COVID-19 on the healthcare industry.

Getty images

News | Coronavirus (COVID-19) | July 16, 2020
July 16, 2020 – Frost and Sullivan’s recent analysis, Post-Pandemic Global Healthcare Market Outlook, 2020, forecasts
Cardiac MRI for four children with clinical diagnosis of acute myocarditis in the setting of COVID-19–related Kawasaki-like symptoms of Multisystem Inflammatory Syndrome in Children (MIS-C). Cardiac MRI of COVID pediatric COVID-19 patients.

Cardiac MRI for four children with clinical diagnosis of acute myocarditis in the setting of COVID-19–related Kawasaki-like symptoms of MIS-C. The top panel demonstrates minimal pericardial effusion on cine images. The second panel demonstrates increased T2-STIR signal intensity with average ratios between myocardium and muscle > 2 in patient 2 (12-year-old male), patient 3 (11-year-old female) and patient 4 (6-year-old female). The third panel demonstrates abnormal native-T1 mapping, which was > 1,100 ms in patients 2, 3 and 4 and normal in patient 1 (8-year-old female). The bottom panel demonstrates absence of late gadolinium enhancement (LGE) in patients 2 and 3. Myocardial null times were recognized as too short in patient 4 but could not be repeated due to lack of further patient cooperation; however review of Look Locker images and additional sequences revealed no LGE. Image courtesy of RSNA.

Feature | Coronavirus (COVID-19) | July 09, 2020
July 8, 2020 — Cardiac...
Older Critically Ill COVID-19 Patients May Have Increased Risk of Bradycardia With Lopinavir and Ritonavir.

Photo copyright American Heart Association, used with permission.

Feature | Coronavirus (COVID-19) | July 09, 2020
July 9, 2020 — Older, critically ill patients with COVID-19 (SARS-CoV-2) who received a combination of the antiretrov
Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), has been the target of threats over his suggestions on how to contain the spread of coronavirus in the U.S. Photo by Jonathan Wyett, U.S. Department of State

Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), has been the target of threats over his suggestions on how to contain the spread of coronavirus in the U.S. Photo by Jonathan Wyett, U.S. Department of State

News | Coronavirus (COVID-19) | July 07, 2020 | Dave Fornell, Editor
July 7, 2020 — In the face of the coronavirus pandemic, public health officials worldwide are working tirelessly to s
Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosai

Thoracic findings in a 15-year-old girl with Multisystem Inflammatory Syndrome in Children (MIS-C). (a) Chest radiograph on admission shows mild perihilar bronchial wall cuffing. (b) Chest radiograph on the third day of admission demonstrates extensive airspace opacification with a mid and lower zone predominance. (c, d) Contrast-enhanced axial CT chest of the thorax at day 3 shows areas of ground-glass opacification (GGO) and dense airspace consolidation with air bronchograms. (c) This conformed to a mosaic pattern with a bronchocentric distribution to the GGO (white arrow, d) involving both central and peripheral lung parenchyma with pleural effusions (black small arrow, d). image courtesy of Radiological Society of North America

Feature | Coronavirus (COVID-19) | June 30, 2020
In recent weeks, a multisystem hyperinflammatory condition has emerged in children in association with prior exposure
Clive Svendsen, Ph.D., director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, at work in his laboratory. Photo by Cedars-Sinai.

Clive Svendsen, Ph.D., director of the Cedars-Sinai Board of Governors Regenerative Medicine Institute, at work in his laboratory. Photo by Cedars-Sinai.

News | Coronavirus (COVID-19) | June 30, 2020
June 30, 2020 — A...
The FDA has determined chloroquine and hydroxychloroquine are not effective at treating novel coronavirus and revoked its earlier emergency use authorization (EUA) for the drugs to be used in COVID-19 patients. FDA says hydroxychloroquine does not work to treat COVID-19.Getty Images #COVID19 #COVID19update #SARSCoV2

The FDA has determined chloroquine and hydroxychloroquine are not effective at treating novel coronavirus and revoked its earlier emergency use authorization (EUA) for the drugs to be used in COVID-19 patients. Getty Images 

Feature | Coronavirus (COVID-19) | June 15, 2020 | Dave Fornell, Editor
June 15, 2020 — The U.S.
Centricity Cardio Enterprise[1] is an integrated Cardiovascular PACS (CVPACS) and Information System (CVIS) that bridges the gaps between care areas and healthcare information systems. You get a single point of access for patient data, wave forms, images, analysis tools and physician reports – combined with powerful end-to-end management, analytics and workflow tools across the cardiovascular care pathway.
Webinar | Coronavirus (COVID-19) | June 10, 2020
The financial burden of COVID-19 has put tremendous pressure on health systems across the country.